Diagnosing peRipheral Lung Lesions With CRYO Biopsies

Launched by ODENSE UNIVERSITY HOSPITAL · Feb 19, 2025

Keywords

ClinConnect Summary

The DR CRYO study is looking at a new way to diagnose lung cancer by comparing two methods of obtaining tissue samples from small lung lesions. Lung cancer is a serious illness, and it's important to get an accurate diagnosis to determine the best treatment. This trial will test a technique called cryo biopsy, which uses a special tool to freeze a small piece of lung tissue for testing. This method may provide larger samples than the traditional forceps biopsy, potentially leading to better diagnoses.

To participate in this study, individuals must be at least 18 years old and undergoing tests for lung cancer due to a lung lesion that is surrounded by normal lung tissue, as seen on a CT scan. Participants will undergo a bronchoscopy, a procedure where a thin tube is inserted into the lungs to collect samples. Importantly, this study is not yet recruiting participants, but it aims to improve how doctors diagnose lung cancer by providing better tissue samples for analysis, which could help in identifying the best treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patients undergoing diagnostic work-up for lung cancer due to a lung lesion surrounded by normal lung tissue (identified by CT)
• • Age 18 or above
• • Bronchoscopy with planned forceps sampling from the lesion
• Exclusion Criteria:
• • - Pregnancy
• • Not able to provide informed consent.